Condition: Alzheimer Disease · Agitation · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com, www.BMSStudyConnect.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 2609 | Chandler, Arizona, United States | Not Yet Recruiting |
| Imaging Endpoints | Scottsdale, Arizona, United States | Recruiting |
| Local Institution - 1657 | Anaheim, California, United States | Not Yet Recruiting |
| Local Institution - 2620 | Canoga Park, California, United States | Not Yet Recruiting |
| Local Institution - 1637 | La Jolla, California, United States | Not Yet Recruiting |
| Local Institution - 2625 | Long Beach, California, United States | Not Yet Recruiting |
| Local Institution - 2607 | Long Beach, California, United States | Not Yet Recruiting |
| Local Institution - 2642 | Long Beach, California, United States | Not Yet Recruiting |
| Local Institution - 2649 | Orange, California, United States | Not Yet Recruiting |
| Local Institution - 2613 | Pasadena, California, United States | Not Yet Recruiting |
| Local Institution - 1662 | Pomona, California, United States | Not Yet Recruiting |
| Local Institution - 1639 | Torrance, California, United States | Not Yet Recruiting |
+ 246 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06937229